Peptide COA access,
row by row.

The exact 5 mg page exposed seller-hosted COA, liquid-chromatography, and mass-spectrometry images. Peptide Local did not verify the represented lot or chain of custody.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page showed a price, ordering control, and COA, HPLC, and mass-spectrometry tabs. A separate stock label was not captured, so it does not set the available low.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller page displayed a 5 mg option, ordering control, and public test-results route. Peptide Local recorded the route without verifying the represented material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page was in stock and displayed a newly added public batch report dated July 16, 2026. Peptide Local did not authenticate custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller lists a certificate with the order. Shipping and testing claims were read from the public product page, not independently verified.

First action: Ask for a sample report and confirm how the included document will identify the current lot.

The seller page exposes separate 10 mg COA, liquid-chromatography, and mass-spectrometry images. Peptide Local verified the public document route, not chain of custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The product page exposes a certificate-of-analysis tab and seller purity claim. Peptide Local did not establish chain of custody or independently sample the material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller states third-party HPLC purity and ESI-MS identity testing. Peptide Local has not commissioned an independent test.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller displays a third-party report. Peptide Local verified that the report link was visible, not the product in the vial.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg variation was purchasable and linked to the seller’s public lot-document library. Peptide Local did not authenticate the batch, chain of custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller page displayed a current 10 mg batch report dated July 7, 2026. Peptide Local recorded the public route without authenticating custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg DAC page displayed an ordering control plus seller-hosted COA, liquid-chromatography, and mass-spectrometry images. The represented material was not independently sampled.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg DAC page showed a price, ordering control, and certificate-of-analysis tab. A separate stock label was not captured, so the row remains availability-unconfirmed.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller page displayed a 5 mg option, ordering control, and public certificate route for CJC-1295 with DAC. Peptide Local did not authenticate the sample, laboratory relationship, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg Modified GRF (1-29) page displayed an ordering control and seller-hosted COA, liquid-chromatography, and mass-spectrometry images. Peptide Local did not authenticate the represented lot.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg no-DAC page showed a list price, ordering control, and certificate-of-analysis tab. A separate stock label was not captured, so this lower price does not set the in-stock headline.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page was marked in stock and described third-party HPLC purity and ESI-MS identity testing, with the batch certificate available by request rather than attached publicly.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The exact 5 mg page displayed an ordering control and seller-hosted COA, liquid-chromatography, and mass-spectrometry images. Document visibility does not establish sample custody or vial identity.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page showed a list price, ordering control, and certificate-of-analysis tab. Because a separate stock statement was not captured, this lower price is not treated as available.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page was marked in stock and described third-party HPLC purity and ESI-MS identity testing. The batch certificate is request-based, and Peptide Local did not sample the vial.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller claims at least 99% HPLC purity and an included COA. Shipping and evidence language were not independently verified.

First action: Ask for a sample report and confirm how the included document will identify the current lot.

Seller states third-party HPLC purity and ESI-MS identity testing. The 100 mg option was marked out of stock when checked.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller links to its testing area from the product page. Peptide Local records the link and seller claim without treating it as independent verification.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 100 mg variation was purchasable and the product route links to the seller’s public COA library. Peptide Local did not authenticate the batch, custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The 100 mg variation was in stock and the page displayed current batch reports dated July 7 and June 5, 2026. Peptide Local did not authenticate custody or contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 100 mcg page displayed a public list price and seller-hosted analytical images. Peptide Local did not establish sample custody, test independence, or correspondence to shipped material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 100 mcg page showed a public price and ordering control. A distinct stock statement was not captured, so the row remains availability-unconfirmed and cannot win the in-stock headline.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The public catalog showed the 0.1 mg starting price while the exact variation was marked out of stock when checked. The row is retained only as unavailable market context.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page was in stock and described third-party HPLC purity and ESI-MS identity testing with the batch certificate available by request.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The seller page displayed a 10 mg option, ordering control, and public test-results route. Peptide Local recorded the route without authenticating custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller spells the product Ipamorlin; its exact 10 mg variation was in stock with a public batch report dated June 21, 2026. Peptide Local did not verify the vial.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page displayed an ordering control and seller-hosted analytical images. Peptide Local did not establish test independence, sample custody, or correspondence to shipped material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page showed a public price, ordering control, and certificate-of-analysis tab. A separate stock statement was not captured, so the row remains availability-unconfirmed.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller catalog showed a $19 to $37 variation range and the public lot library included a 10 mg Kisspeptin-10 certificate; the 10 mg board uses the range maximum. Peptide Local did not authenticate the lot.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page showed a list price, ordering control, and certificate-of-analysis tab. A distinct stock statement was not captured, so this row remains availability-unconfirmed.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page displayed an in-stock offer and described independent HPLC purity plus ESI-MS identity documentation on request. Peptide Local did not sample the vial.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The exact 10 mg MT1 page was marked in stock and linked current public batch reports. Peptide Local recorded the route without certifying the laboratory relationship, custody, or contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page showed analytical-document tabs and a public list price but was explicitly marked out of stock. It is retained for market context and excluded from the available low.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page displayed the list price, an out-of-stock label, and seller language describing third-party HPLC and ESI-MS documentation on request. Peptide Local did not obtain or authenticate the vial.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The exact 10 mg MT2 page was marked in stock and displayed a current public batch-report route. Peptide Local recorded the route without certifying the laboratory relationship or contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller claims at least 98% HPLC purity and an included COA. Shipping and evidence language were not independently verified.

First action: Ask for a sample report and confirm how the included document will identify the current lot.

The public product page exposes 10 mg COA, liquid-chromatography, and mass-spectrometry images. Peptide Local did not verify the represented lot, chain of custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The public product page displays a certificate-of-analysis tab and a greater-than-99% seller purity claim. Peptide Local did not independently verify the vial.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller states third-party HPLC purity and ESI-MS identity testing. Peptide Local has not independently sampled the vial.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller links a laboratory report for a 10 mg lot. Peptide Local verified the public document link, not chain of custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg variation was purchasable and the seller links a public lot-specific COA library. Peptide Local did not authenticate the batch, chain of custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The 10 mg variation was in stock and the public page displayed recent batch reports, including June 21, 2026. Peptide Local did not authenticate custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller lists a certificate with the order and at least 99% HPLC purity. Peptide Local recorded the public claim without independently sampling the material.

First action: Ask for a sample report and confirm how the included document will identify the current lot.

Seller states third-party HPLC purity and ESI-MS identity testing with a batch certificate available on request. Peptide Local did not sample the vial.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller displays public testing reports from the product page. Peptide Local verified the document route, not chain of custody or the material in the vial.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The 1000 mg variation was in stock and linked public batch reports dated July 16 and June 7, 2026. Peptide Local did not authenticate custody or independently test the material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page exposed seller-hosted COA, liquid-chromatography, and mass-spectrometry images. Peptide Local did not verify the represented lot or chain of custody.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page showed a price, ordering control, and certificate-of-analysis tab. A separate stock label was not captured, so it does not set the available low.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page was in stock and described third-party HPLC purity and ESI-MS identity testing with a batch certificate available by request.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The exact 10 mg page showed a price plus certificate, HPLC, and mass-spectrometry sections. A separate stock label was not captured, and the material was not sampled.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page was in stock and described third-party HPLC purity and ESI-MS identity testing with a batch certificate available by request.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The exact 10 mg page was in stock and displayed current public batch reports, including June 5, 2026. Peptide Local did not authenticate custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page was marked in stock and described independent HPLC purity and ESI-MS identity testing, with the batch certificate supplied on request rather than posted publicly.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The 10 mg page displayed an ordering control and a third-party report route with batch, purity, date, laboratory, and verification key. Peptide Local did not commission the analysis.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg page was marked in stock and linked current public batch reports, including a June 22, 2026 record. Peptide Local did not authenticate the custody trail or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page displayed an ordering control and seller-hosted analytical images. Peptide Local did not commission the testing or verify that the represented batch corresponds to shipped material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page exposed a price, ordering control, and certificate-of-analysis tab. A distinct stock statement was not captured, so the row is availability-unconfirmed.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg listing was marked in stock and described independent HPLC purity and ESI-MS identity documentation available by request. Peptide Local did not obtain the vial.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller claims at least 99% HPLC purity and an included COA. The page also notes a possible 5–7 day low-stock delay.

First action: Ask for a sample report and confirm how the included document will identify the current lot.

The seller page exposes 10 mg COA, liquid-chromatography, and mass-spectrometry images. Peptide Local verified that access path without establishing chain of custody or testing the material.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The 10 mg option and certificate-of-analysis tab were visible on the public page. No separate stock label was captured, and the material was not independently sampled.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller states third-party HPLC purity and ESI-MS identity testing. The underlying vial was not independently sampled by Peptide Local.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

Seller links two third-party reports dated May 2026. A visible report is evidence of a claim, not independent chain of custody.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg variation was purchasable and the seller exposes a public lot-document library. Peptide Local did not authenticate the represented batch, custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller page displayed current 10 mg batch reports dated July 5 and May 18, 2026. Peptide Local did not authenticate custody or independently sample the vial.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller page exposes separate 10 mg COA, liquid-chromatography, and mass-spectrometry images. Peptide Local verified the public document route, not chain of custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The 10 mg option and certificate-of-analysis tab were visible on the public page. No separate stock label was captured, and the material was not independently sampled.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

Seller states independent HPLC purity and ESI-MS identity testing with a batch certificate available on request. Peptide Local did not sample the material.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The public product page displays a third-party report for a 10 mg listing. Peptide Local recorded the report route without verifying chain of custody or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 10 mg variation was purchasable and the seller links its public batch-document library. Peptide Local did not authenticate the represented lot, custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The seller page showed a 5 mg to 10 mg price range whose lower value corresponds to the 5 mg variation, plus an analytical-document tab. A separate stock label was not captured.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.

The exact 5 mg page was marked in stock and described independent HPLC purity and ESI-MS identity testing, with the batch certificate available by request rather than publicly attached.

First action: Request the current-lot report, analytical methods, date, and laboratory verification route before relying on the claim.

The seller page displayed a 5 mg option, ordering control, and public certificate-library route. Peptide Local did not verify laboratory independence, sample custody, or vial contents.

First action: Open the published route and match compound, nominal size, lot or batch, report date, and named laboratory.